High-Risk, Non-Muscle-Invasive Bladder Cancer: Recent Updates to KEYNOTE-057 Trial Data

home / investigator-perspectives / high-risk-non-muscle-invasive-bladder-cancer-recent-updates-to-keynote-057-trial-data

Eric A. Singer, MD, MA, FACS, an expert urologic oncologist, discusses recent data from KEYNOTE-057 presented at the 2023 American Urological Association (AUA) Annual Meeting, and offers clinical insights on treatment paradigms for non-muscle-invasive bladder cancer.

© 2024 MJH Life Sciences

All rights reserved.